The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

WeightWatchers is shaking up its leadership. WW International announced Friday that CEO Sima Sistani would leave her role ...

People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Nestle launched frozen meals tailored for people on weight-loss drugs like Ozempic and Wegovy. We tried the teriyaki chicken ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two ...

On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.

In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...

The CEO of the company that makes Olympic and Wegovy was on Capitol Hill this week—asked by senators why popular diabetes and weight loss drugs are so much pricer in the U.S. compared to other ...

A new study published in JAMA Network Open contends that women may lose more weight on semaglutides like Ozempic than men.

The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.